[CQM-5715] CMS127v11 clarification on reporting to CMS for MIPS 2022 Created: 10/14/22 Updated: 02/28/24 Resolved: 11/02/22 |
|
| Status: | Closed |
| Project: | eCQM Issue Tracker |
| Component/s: | None |
| Type: | EC eCQMs - Eligible Clinicians | Priority: | Moderate |
| Reporter: | Mary Kelly (Inactive) | Assignee: | Mathematica EC eCQM Team |
| Resolution: | Answered | Votes: | 0 |
| Labels: | None | ||
| Contact Name: | Mary Kelly |
| Contact Email: | m2kelly@sbch.org |
| Contact Phone: | 8053249403 |
| Institution/Name: | Cottage Health |
| Solution: | Thank you for you inquiry about CMS127v10. Unspecified formulations of the pneumococcal vaccine may count towards the numerator criteria given they were received during the required timeframe with the appropriate age requirement. For the performance year 2022, implementers may map additional formulations of the pneumococcal conjugate vaccine, including pneumococcal conjugate vaccine 13 valent, pneumococcal conjugate vaccine 15 valent, and pneumococcal conjugate vaccine 20 valent, to the pneumococcal vaccine, unspecified formulation code (CVX code 109) in the Pneumococcal Polysaccharide 23 Vaccine (OID: 2.16.840.1.113883.3.464.1003.110.12.1089) value set.
​Unfortunately, the portion of your inquiry specific to CMS suppression of data, is out of scope for the eCQM Issue Tracker. Your question has been redirected to the QualityNet Service Desk where the following ticket is open for you: CS1778421 You will be contacted by their team, and assigned a customer service representative who will work to resolve your inquiry. We are closing this ticket now. Please let us know if you have any additional questions about eCQM logic or specifications. |
| Solution Posted On: | |
| 2023 Performance Period EC eCQMs: |
CMS0127v11
|
| Impact: | CMS127v11 clarification on reporting to CMS for MIPS 2022 |
| Description |
|
Clarification question - if we submit performance data on this measure for 2022 even though there is a known issue that pneumococcal vaccine does not currently contain the specific codes to capture administration of the pneumococcal conjugate vaccine 15 valent or the pneumococcal conjugate vaccine 20 valent, will we still get performance credit for other vaccine types administered and reported or will CMS suppress that data? Thank you. |
| Comments |
| Comment by Mathematica EC eCQM Team [ 10/31/22 ] |
|
We apologize for the delay in providing a response for your question. We continue to investigate the issue noted in your ticket and will provide a response as soon as we are able. Thank you for your continued patience. |
| Comment by Mathematica EC eCQM Team [ 10/24/22 ] |
|
We continue to investigate the issue noted in your ticket and will provide a response as soon as we are able. Thank you for your patience. |
| Comment by Mathematica EC eCQM Team [ 10/17/22 ] |
|
Thank you for submitting your question. We will review your ticket and provide a response as soon as possible. |